Delighted to Share a Proud Moment for Our Team

At the 19th China Pharmaceutical Development Award Ceremony held in Beijing, our company’s senior leadership, Mr Liu Jiankai, was honored with the Outstanding Achievement Award — one of the earliest national-level pharmaceutical awards approved by China’s Ministry of Science and Technology. This recognition celebrates exceptional contributions to pharmaceutical science and long-standing dedication to improving public health.

We are proud that this award acknowledges not only individual excellence but also Biokangtai Group's collective innovation capacity. In recent years, our team has successfully advanced 12 commercialized vaccines — including the world’s first dual-vector PCV13 — and continues to accelerate frontier programs such as next-generation combination vaccines, and a therapeutic vaccine designed to reduce HBV relapse

This achievement inspires us to continue driving scientific innovation, elevating product quality, and contributing meaningful solutions to global healthcare.